ConductScience.org, home

Paper8409404

C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells.

van den Dobbelsteen ME and 5 others. J Immunol, 1993. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells. Papers, record 8409404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8409404

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
C1Q, a subunit of the first component of complement, enhances the binding of aggregated IgG to rat renal mesangial cells.
PubMed
Journal
J Immunol
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.37
iCite
Revised in PubMed
2017-11-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van den Dobbelsteen MEM E
2van der Woude FJF J
3Schroeijers WEW E
4Klar-Mohamad NN
5van Es LAL A
6Daha MRM R

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement C1qMajor topic
Glomerular MesangiumMajor topic
Hyaluronan ReceptorsMajor topic
Immunoglobulin GMajor topic
Membrane GlycoproteinsMajor topic
Animals
Carrier Proteins
Cells, Cultured
Humans
Mitochondrial Proteins
Molecular Weight
Rats
Rats, Sprague-Dawley
Receptors, Complement
Receptors, IgG

Source PubMed

Download CSV of topics

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
20180137C1q nephropathy in the pediatric population: pathology and pathogenesis.Pediatr Nephrol2010https://conductscience.org/library/papers/20180137PubMed
9486404Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).Clin Exp Immunol1998https://conductscience.org/library/papers/9486404PubMed
7545301
Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1.
Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7545301PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C1QBP708PubTator's text mininghttps://conductscience.org/library/genes/708NCBI Gene
CD9322918PubTator's text mininghttps://conductscience.org/library/genes/22918NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8409404

GET https://conductscience.org/api/papers/v1/8409404/authors